The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease - PubMed (original) (raw)
Comparative Study
. 1993 May 11;32(18):4693-7.
doi: 10.1021/bi00069a001.
Affiliations
- PMID: 8490014
- DOI: 10.1021/bi00069a001
Comparative Study
The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease
J T Jarrett et al. Biochemistry. 1993.
Abstract
Several variants of the beta amyloid protein, differing only at their carboxy terminus (beta 1-39, beta 1-40, beta 1-42, and beta 1-43), have been identified as the major components of the cerebral amyloid deposits which are characteristic of Alzheimer's disease. Kinetic studies of aggregation by three naturally occurring beta protein variants (beta 1-39, beta 1-40, beta 1-42) and four model peptides (beta 26-39, beta 26-40, beta 26-42, beta 26-43) demonstrate that amyloid formation, like crystallization, is a nucleation-dependent phenomenon. This discovery has practical consequences for studies of the beta amyloid protein. The length of the C-terminus is a critical determinant of the rate of amyloid formation ("kinetic solubility") but has only a minor effect on the thermodynamic solubility. Amyloid formation by the kinetically soluble peptides (e.g., beta 1-39, beta 1-40, beta 26-39, beta 26-40) can be nucleated, or "seeded", by peptides which include the critical C-terminal residues (beta 1-42, beta 26-42, beta 26-43, beta 34-42). These results suggest that nucleation may be the rate-determining step of in vivo amyloidogenesis and that beta 1-42 and/or beta 1-43, rather than beta 1-40, may be the pathogenic protein(s) in AD.
Similar articles
- The C-terminus of the beta protein is critical in amyloidogenesis.
Jarrett JT, Berger EP, Lansbury PT Jr. Jarrett JT, et al. Ann N Y Acad Sci. 1993 Sep 24;695:144-8. doi: 10.1111/j.1749-6632.1993.tb23043.x. Ann N Y Acad Sci. 1993. PMID: 8239273 Review. - A kinetic model for amyloid formation in the prion diseases: importance of seeding.
Come JH, Fraser PE, Lansbury PT Jr. Come JH, et al. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):5959-63. doi: 10.1073/pnas.90.13.5959. Proc Natl Acad Sci U S A. 1993. PMID: 8327467 Free PMC article. - Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB.
Jarrett JT, Lansbury PT Jr. Jarrett JT, et al. Biochemistry. 1992 Dec 15;31(49):12345-52. doi: 10.1021/bi00164a008. Biochemistry. 1992. PMID: 1463722 - Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
Watson D, Castaño E, Kokjohn TA, Kuo YM, Lyubchenko Y, Pinsky D, Connolly ES Jr, Esh C, Luehrs DC, Stine WB, Rowse LM, Emmerling MR, Roher AE. Watson D, et al. Neurol Res. 2005 Dec;27(8):869-81. doi: 10.1179/016164105X49436. Neurol Res. 2005. PMID: 16354549 Review.
Cited by
- Novel Monoclonal Antibody Specific toward Amyloid-β Binds to a Unique Epitope within the N-Terminal Region.
Paterno G, Moore BD, Bell BM, Gorion KM, Ran Y, Prokop S, Golde TE, Giasson BI. Paterno G, et al. Antibodies (Basel). 2024 Aug 9;13(3):68. doi: 10.3390/antib13030068. Antibodies (Basel). 2024. PMID: 39189239 Free PMC article. - Alpha-lipoic acid alleviates cognitive deficits in transgenic APP23/PS45 mice through a mitophagy-mediated increase in ADAM10 α-secretase cleavage of APP.
Zhang J, Jiang Y, Dong X, Meng Z, Ji L, Kang Y, Liu M, Zhou W, Song W. Zhang J, et al. Alzheimers Res Ther. 2024 Jul 19;16(1):160. doi: 10.1186/s13195-024-01527-3. Alzheimers Res Ther. 2024. PMID: 39030577 Free PMC article. - An N-terminal acidic β-sheet domain is responsible for the metal-accumulation properties of amyloid-β protofibrils: a molecular dynamics study.
Gómez-Castro CZ, Quintanar L, Vela A. Gómez-Castro CZ, et al. J Biol Inorg Chem. 2024 Jun;29(4):407-425. doi: 10.1007/s00775-024-02061-1. Epub 2024 May 29. J Biol Inorg Chem. 2024. PMID: 38811408 Free PMC article. - The Cerebrospinal Fluid Free-Glycans Hex1 and HexNAc1Hex1Neu5Ac1 as Potential Biomarkers of Alzheimer's Disease.
Krüger L, Biskup K, Schipke CG, Kochnowsky B, Schneider LS, Peters O, Blanchard V. Krüger L, et al. Biomolecules. 2024 Apr 24;14(5):512. doi: 10.3390/biom14050512. Biomolecules. 2024. PMID: 38785920 Free PMC article. - Exploring Structural Insights of Aβ42 and α-Synuclein Monomers and Heterodimer: A Comparative Study Using Implicit and Explicit Solvent Simulations.
Varenyk Y, Theodorakis PE, Pham DQH, Li MS, Krupa P. Varenyk Y, et al. J Phys Chem B. 2024 May 16;128(19):4655-4669. doi: 10.1021/acs.jpcb.4c00503. Epub 2024 May 3. J Phys Chem B. 2024. PMID: 38700150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical